Browse Articles

Comparing the Dietary Preference of Caenorhabditis elegans for Bacterial Probiotics vs. Escherichia coli.

Lulla et al. | Dec 18, 2020

Comparing the Dietary Preference of <i>Caenorhabditis elegans</i> for Bacterial Probiotics vs. <i>Escherichia coli</i>.

In this experiment, the authors used C. elegans as a simple model organism to observe the impact of probiotics on the human digestive system. The results of the experiments showed that the C. elegans were, on average, most present in Chobani cultures over other tested yogurts. While not statistically significant, these results still demonstrated that C. elegans might prefer Chobani cultures over other probiotic yogurts, which may also indicate greater gut benefits from Chobani over the other yogurt brands tested.

Read More...

Expression of Anti-Neurodegeneration Genes in Mutant Caenorhabditis elegans Using CRISPR-Cas9 Improves Behavior Associated With Alzheimer’s Disease

Mishra et al. | Sep 14, 2019

Expression of Anti-Neurodegeneration Genes in Mutant <em>Caenorhabditis elegans</em> Using CRISPR-Cas9 Improves Behavior Associated With Alzheimer’s Disease

Alzheimer's disease is one of the leading causes of death in the United States and is characterized by neurodegeneration. Mishra et al. wanted to understand the role of two transport proteins, LRP1 and AQP4, in the neurodegeneration of Alzheimer's disease. They used a model organism for Alzheimer's disease, the nematode C. elegans, and genetic engineering to look at whether they would see a decrease in neurodegeneration if they increased the amount of these two transport proteins. They found that the best improvements were caused by increased expression of both transport proteins, with smaller improvements when just one of the proteins is overly expressed. Their work has important implications for how we understand neurodegeneration in Alzheimer's disease and what we can do to slow or prevent the progression of the disease.

Read More...